Trinity Biotech (TRIB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Trinity Biotech plc has strategically bolstered its marketing leadership by appointing David Ouston as the new Biosensor Marketing Director, bringing his extensive experience in glucose monitoring and diabetes care to the company. Ouston’s expertise in global markets and digital solutions for diabetes management is expected to drive the growth and market penetration of Trinity’s innovative, needle-free, continuous glucose monitoring technology. His previous roles at Johnson & Johnson and LifeScan have equipped him with the skills to support Trinity Biotech’s mission to improve public health through wearable biosensor technology and wellness analytics.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
